Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 1 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Recs

0
Player Avatar EMG114 (< 20) Submitted: 4/23/2008 3:27:37 PM : Outperform Start Price: $7.04 INFI Score: +81.49

Good investment for the long-term...

Featured Broker Partners


Advertisement